Assessment of oral clonidine premedication on postoperative pain and agitation following cataract surgery under general anesthesia

Status

Active, not recruiting

Phases

Phase 3

Study type

Interventional

Source

IRCT

Registry ID

IRCT20170213032560N2

Enrollment

Registered

2018-07-30

Start date

2016-10-11

Completion date

Unknown

Last updated

2018-09-11

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Condition 1: H25.0 Senile incipient cataract H57.1 ocular pain. Condition 2: H25.0 Senile incipient cataract H57.1 ocular pain. Ocular pain Age-related incipient cataract

Interventions

Intervention 1: In intervention group, participant takes oral clonidine (Tablet 0.2 mg manufactured by Tolidaru corporation) with 30ml water one hour before operation. Ophthalmology ward nurse who is

Eligibility

Sex/Gender

All

Age

18 Years to 85 Years

Inclusion criteria

Inclusion criteria: Age: 18-85 years ASA class 1& 2 & 3

Exclusion criteria

Exclusion criteria: Exclusion criteria: A history of drug abuse, antihypertensive therapy, antidepressant, anticonvulsive, beta blocker, Fluvoxamine, digoxin, dextromethorphan and every complication during surgery or anesthesia

Design outcomes

Primary

Measure	Time frame
Pain, burning, foreign body sensation in the eye. Timepoint: 15min 30min 45min 60min 1h 2h 3h 4h 12h 18h 24h after operation. Method of measurement: Researcher uses 0-10 numeric pain rating scale for assessment of postoperative pain.	—

Countries

Iran (Islamic Republic of)

Contacts

Public Contactmahsa kalantari

Shahroud University of Medical Sciences

mahsa.kalantari92@yahoo.com+98 23 3239 5054

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026